Cryptococcosis: clinical and biological aspects

References

• Casadevall A, Perfect JR. Cryptococcus neoformans. Washing-ton DC: American Society for Microbiology Press, 1998.
   Google Scholar
• Dromer F, Mathoulin S, Dupont B, Laporte A, the French Cryptococcosis Study Group. Epidemiology of cryptococcosis in France: 9-year survey (1985-1993). Clin Infect Dis 1996; 23: 82–90.
   Google Scholar
• Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin 0, the French Cryptococcosis Study Group. Individual and environ-mental factors associated with Cryptococcus neoformans serotype D infections in France. Clin Infect Dis 1996; 23: 91–96.
   Google Scholar
• Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann Intern Med 1974; 80: 176–181.
   PubMed Web of Science ®Google Scholar
• Dismukes WE, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317: 334–341.
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin S, Dupont B, Brugière 0, Letenneur L, the French Cryptococcosis Study Group. Comparison of am-photericin B and fluconazole efficacy in the treatment of crypto-coccosis in HIV-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996; 22 (Suppl. 2): 154–160.
   Google Scholar
• Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83–89.
   PubMed Web of Science ®Google Scholar
• Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodefi-ciency syndrome. Diagnostic features and outcome of treat-ment. Ann Intern Med 1986; 104: 234–240.
   Google Scholar
• Lortholary 0, Dromer F, Fitting C, et al. CSF cytokine profiles as markers of meningeal involvement and potential prognostic indicators during cryptococcosis in hiv-infected (HIV+ ) and -non-infected (HIV-) patients. 4th International Conference on Cryptococcus and Cryptococcosis. London, September 12–16, 1999; Abstract F15.
   Google Scholar
• Lortholary 0, Improvisi L, Rayhane N, et al. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun 1999; 67: 6314–6320.
   Google Scholar
• Garcia-Hermoso D, Dromer F, Janbon G. Are two Cryptococ-cus neoformans strains epidemiologically linked? 14th Congress of the International Society for Human and Animal Mycology, Buenos Aires, Argentina, May 8–12, 2000. ISHAM, 2000: Abstract 169.
   Google Scholar
• Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37: 3204–3209.
   Google Scholar
• Kwon-Chung K, Bennett JE. Medical Mycology: Philadelphia PA: Lea and Febiger, 1992.
   Google Scholar
• Casadevall A, Perfect JR. Cryptococcus neoformans. Washing-ton DC: American Society for Microbiology Press, 1998.
   Google Scholar
• Marquis G, Montplaisir S, Pelletier M, Mousseau S, Auger P. Genetic resistance to murine cryptococcosis: increased suscepti-bility in the CBA/N X1D mutant strain of mice. Infect Immun 1985; 47: 282–287.
   Google Scholar
• Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45: 187–218.
   PubMed Web of Science ®Google Scholar
• Rhodes JC, Polacheck I, Kwon-Chung KJ. Phenoloxidase ac-tivity and virulence in isogenic strains of Cryptococcus neo-formans. Infect Immun 1982; 36: 1175–1184.
   Google Scholar
• Liu L, Wakamatsu K, Ito S, Williamson PR. Catecholamine oxidative products but not melanin, are produced by Crypto-coccus neoformans during neuropathogenesis in mice. Infect Immun 1999; 67: 108–112.
   PubMed Web of Science ®Google Scholar
• Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000; 68: 443–448.
   Google Scholar
• Kwon-Chung KJ, Edman JC, Wickes BL. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 1992; 60: 602–605.
   Google Scholar
• Alspaugh JA, Perfect JR, Heitman J. Cryptococcus neoformans mating and virulence are regulated by G-protein a-subunit GPA1 and cAMP. Genes Dev 1997; 11: 3206–3327.0 2000 SHAM, Medical Mycology, 38, Suppl. 1, 205-213
   Google Scholar
• Odom A, Muir S, Lim E, Toffaletti DL, Perfect JR, Heitman J. Calcineurin is required for virulence of Cryptococcus neofor-mans. EMBO J 1997; 16: 2576–2589.
   PubMed Web of Science ®Google Scholar
• Aoki S, Ito-Kuwa S, Nakamura K, Kato J, Ninomiya K, Vidotto V. Extracellular proteolytic activity of Cryptococcus neoformans. Mycopathol 1994; 128: 143–150.
   PubMedGoogle Scholar
• Chen L-C, Casadevall A. Variants of a Cryptococcus neofor-mans strain elicit different inflammatory responses in mice. Clin Diagn Lab Immunol 1999; 6: 266–268.
   Google Scholar
• Ruma-Haynes P, Brownlee AG, Sorrell TC. A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 solates. J Gen Microbiol 2000; 49: 733–737.
   Google Scholar
• Chen SC, Wright LC, Santangelo RT, et al. Identification of extracellular phospholipase B, lysophospholipase and acyl transferase activities in the basidiomycetous fungus Cryptococ-cus neoformans. Infect Immun 1997; 65: 405–411.
   PubMed Web of Science ®Google Scholar
• Chen SCA, Wright LC, Golding JC, Sorrell TC. Purification and characterization of secretory phospholipase B, lysophos-pholipase and lysophospholipase transacylasc from a virulent train of the pathogenic fungus, Cryptococcus neoformans. Biochem J 2000. In press.
   Google Scholar
• Santangelo RT, Hook J, Weinberger R, Sorrell TC, Wright LC. Development of an ELISA for detection of cryptococcal phos-pholipase antibodies. 4th International Conference on Crypto-coccus and Cryptococcosis, London, September 12–16, 1999; Abstract PC 20.
   Google Scholar
• Chen SCA, Muller M, Thou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new viru-lence factor? J Infect Dis 1997; 175: 414–420.
   Google Scholar
• Kwon-Chung KJ, Bennett JE. Epidemiologic differences be-tween the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123–130.
   Google Scholar
• Chen SCA, Sorrell TC, Nimmo G, et al. Epidemiology and host and variety-dependent characteristics of infection due to Cryptococcus neoformans. Clin Infect Dis 2000. In press.
   Google Scholar
• Speed BR, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28–34.
   PubMed Web of Science ®Google Scholar
• Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, Carter DA. Presence of a and a mating types in environmental and clinical collections of Cryptococcus neoformans var gattii strains from Australia. J Clin Microbiol 1999; 37: 2920–2926.
   PubMedGoogle Scholar
• Bubb WA, Wright LC, Cagney M, Santangelo RT, Sorrell TC, Kuchel PW. Heteronuclear NMR studies of metabolites pro-duced by Cryptococcus neoformans in culture media: identifica-tion of possible virulence factors. Magn Reson Med 1999; 42: 442–453.
   PubMedGoogle Scholar
• Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun 1999; 67: 885–890.
   PubMed Web of Science ®Google Scholar
• Leone R, Cabeli P, Sinicco A, Ito-Kuwa S, Soki S, Vidotto V. Relationship between protease production and capsule size in Cryptococcus neoformans. J Mycol Med 1999; 9: 42–44.
   Google Scholar
• Santangelo RT, Nouri-Sorkhabi MH, Sorrell TC, et al. Bio-chemical and functional characterisation of secreted phospholi-pase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol 1999; 48: 731–740.
   PubMedGoogle Scholar
• Cox GM, McDade HC, Gottfredsson M, et al. Phospholipase B is a virulence factor for Cryptococcus neoformans. American Society for Microbiology, Los Angeles, May 21–25, 2000; Abstract F–18.
   Google Scholar
• Latouche GN, Lorenz M, Sorrell TC, et al. Isolation and characterisation of the phospholipase B gene of Cryptococcus neoformans var. gattii. 4th International Conference on Crypto-coccus and Cryptococcosis, London, September 12–16, 1999; Abstract PA2.
   Google Scholar
• Cox GM, Toffaletti L, Perfect JR. Dominant selection system for use in Cryptococcus neoformans. J Med Vet Mycol 1997; 34: 385–391.
   Google Scholar
• Varma A, Kwon-Chung KJ. Characterization of the glyceralde-hyde-3-phosphate dehydrogenase gene and the use of its pro-motor for heterologous expression in Cryptococcus neoformans, a human pathogen. Gene 1999; 232: 155–163.
   PubMedGoogle Scholar
• Latouche GN, Cox GM, Sorrell TC, Perfect JR, Meyer W. Development of a transformation system for C. neoformans var. gattii by biolistic transfer of DNA. 4th International Conference on Cryptococcus and Cryptococcosis, London, September 12–16, 1999; Abstract PA3.
   Google Scholar
• Mody CH, Lipscomb MF, Street NE, Toews GB. Depletion of CD4 + (L3T4 +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol 1990; 144: 1472–1477.
   PubMedGoogle Scholar
• Duncan RA, von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4 + T-lymphocytopenia — Four pa-tients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993; 328: 393–398.
   PubMed Web of Science ®Google Scholar
• Diamond RD. Cryptococcus neoformans. In: Mandell GL, Ben-nett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th edn. New York: Churchill Livingstone Inc., 1995: 2331–2340.
   Google Scholar
• Murphy JW. Influence of cryptococcal antigens on cell-medi-ated immunity. Rev Infect Dis 1988; 10: S432—S435.
   Google Scholar
• Murphy JW, Mosley RL, Cherniak R, Reyes GH, Kozel TR, Reiss E. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56: 424–431.
   PubMed Web of Science ®Google Scholar
• Hoy JF, Murphy JW, Miller GG. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infec-tion. J Infect Dis 1989; 159: 116–119.
   Google Scholar
• Levitz SM, North EA. Lymphoproliferation and cytokines profiles in human peripheral blood mononuclear cells stimu-lated by Cryptococcus neoformans. J Med Vet Mycol 1997; 35: 229–236.
   PubMedGoogle Scholar
• Pitzurra L, Vecchiarelli A, Peducci R, Cardinali A, Bistoni F. Identification of a 105 kilodalton Cryptococcus neoformans mannoprotein involved in human cell-mediated immune re-sponse. J Med Vet Mycol 1997; 35: 299–303.
   Google Scholar